BENGALURU: Sangita Singh Wipro 's former chief executive for healthcare and life sciences, is likely to join Infosys as executive vice-president (EVP) and head its nearly $800-million healthcare and life sciences portfolio.Singh, who left Wipro last December after a stellar career of 23 years, is expected to be based in one of the key customer markets - either the US or Europe - and report to Mohit Joshi, president and head of financial services in Infosys. The healthcare vertical vacancy was created by the exit of executive VP Manish Tandon , who joined IT services company CSS Corp as CEO recently. Singh, who is likely to join Infosys in December - some sources said she has a one-year non-compete clause with Wipro - had in her previous role engaged with top clients in the healthcare payer, provider, medical devices and life sciences spaces. She had direct oversight of some of Wipro's top accounts such as Johnson & Johnson, Novartis, Astra Zeneca and Takeda. Indian IT companies have had to face the brunt of the collapse in the proposed merger of Pfizer and Allergan.

Source: Times of India August 25, 2016 03:02 UTC